Shengqiang Mao

Shengqiang Mao

Auto-generated profile, based on publicly available information

Shengqiang Mao

Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 February 2024 in Nature Aging
Verified
Journal Article
Open access
PDF file
XWXinyuan Wang
Xinyuan Wang
YLYaru Luo
Yaru Luo
SHSiyu He
Siyu He
YLYing Lu
Ying Lu
YGYanqiu Gong
Yanqiu Gong
LDLunzhi Dai
Lunzhi Dai
The incidence of intestinal diseases increases with age, yet the mechanisms governing gut aging and its link to diseases, such as colorectal cancer (CRC), remain elusive. In this study, while considering age, sex and proximal–distal variations, we used a multi-omics approach in non-human primates (Macaca fascicularis) to shed light on the heterogeneity of intestinal aging and identify potential regulators of gut aging. We explored the roles of several regulators, including those from tryptophan metabolism, in intestinal function and lifespan inCaenorhabditis elegans. Suggesting conservation of region specificity, tryptophan metabolism via the kynurenine and serotonin (5-HT) pathways varied between the proximal and distal colon, and, using a mouse colitis model, we observed that distal colitis was more sensitive to 5-HT treatment. Additionally, using proteomics analysis of human CRC samples, we identified links between gut aging and CRC, with high HPX levels predicting poor prognosis in older patients with CRC. Together, this work provides potential targets for preventing gut aging and associated diseases.

8 April 2023 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
YYYongfeng Yang
Yongfeng Yang
YYYing Yang
Ying Yang
Hong HuangHong Huang
Hong Huang
TSTingting Song
Tingting Song
SMShengqiang Mao
Shengqiang Mao
WLWeimin Li
Weimin Li
Extrachromosomal circular DNAs (eccDNAs) participate in tumorigenesis and tumor progression. However, the role and mechanism of eccDNAs have yet to be elucidated in non-small cell lung cancer (NSCLC). In our research, three surgically matched NSCLC tissue samples, NSCLC cell lines (H1299, A549, and H460), and a normal lung cell line (MRC-5) were used as study objects. High-throughput eccDNA sequencing and bioinformatics analysis were performed to study the distribution pattern and level of eccDNA expression. The upregulated candidate eccDNA-encoding PLCG2 was validated by routine PCR. Plasmid transfection, RNA interference, qRT‒PCR and western blotting experiments were used to verify the expression level of PLCG2. Our results showed that the chromosome distribution, length distribution, and genomic annotation of the eccDNAs were comparable between the NSCLC and normal groups. Nevertheless, there were no significant differences in eccDNAs between NSCLC tissues and matched normal lung tissues. The eccDNA derived from PLCG2 was upregulated in NSCLC cells. TCGA analysis and immunohistochemistry showed that PLCG2 was highly expressed in lung cancer tissues and tended to be associated with poor outcome. We also demonstrated that PLCG2 can promote metastasis through the regulation of mitochondrial respiration. These results suggested that PLCG2 identified by eccDNA sequencing acts as an oncogene and might be a new biomarker for NSCLC diagnosis and prognosis evaluation.

14 July 2025 in eLife
Verified
Journal Article
Open access
Hong HuangHong Huang
Hong Huang
YYYing Yang
Ying Yang
QZQiuju Zhang
Qiuju Zhang
YYYongfeng Yang
Yongfeng Yang
ZXZhenqi Xiong
Zhenqi Xiong
LZLe Zhang
Le Zhang
Lung cancer is preceded by premalignant lesions, and what factors drive this transformation and the potential regulatory mode in the context of tumor initiation remain to be elucidated. In the course of precancerous lesions in mice, we found a phasic shift in metabolic patterns. Macrophages are a heterogeneous cell population with high plasticity in the tumor microenvironment. Single-cell interaction and metabolic analyses highlighted a cellular state, S100a4+ alveolar macrophages, which exhibited distinct fatty acid metabolic activity, such as palmitic acid metabolism, at the atypical adenomatous hyperplasia stage, accompanied by an angiogenic-promoting function in a pre-neoplastic setting of mice. These findings were reproducible in human single-cell transcriptomes and had been confirmed by histopathological staining and in vitro cell coculture assays. Taken together, the results from this study demonstrated that the S100a4+ alveolar macrophage subset contributes to tumorigenesis by altering its metabolic state, suggesting that metabolic interventions targeting this cell state in the early stage of disease may delay neoplastic transformation of the lung epithelium.

1 December 2025 in APL Bioengineering
Verified
Journal Article
Open access
SMShengqiang Mao
Shengqiang Mao
JJJiayi Jiang
Jiayi Jiang
ZLZhiqiang Liu
Zhiqiang Liu
YLYi Li
Yi Li
Idiopathic pulmonary fibrosis (IPF), a progressive and fatal lung disease, significantly increases the risk of lung cancer, particularly lung adenocarcinoma (LUAD). However, the shared genetic mechanisms driving IPF and LUAD comorbidities remain poorly understood, necessitating integrated multi-omics investigations. Through bulk and single-cell transcriptomic analyses, we identified 308 shared differentially expressed genes enriched in lipid metabolism and immune-inflammatory processes. Additionally, single-cell profiling revealed significant alterations in epithelial cells and macrophage populations between LUAD and IPF tissues, underscoring their role in disease progression. Furthermore, the copy number variation profiling identified a premalignant epithelial subpopulation in IPF exhibiting transcriptional signatures resembling LUAD malignant epithelial cells, and trajectory analysis illustrated a potential temporal progression toward malignancy. To identify co-causal genes, we performed weighted gene coexpression network analysis, defining modules associated with key cell types involved in comorbidities. Moreover, leveraging 101 algorithm combinations across ten machine learning approaches, we constructed a robust prognostic model, pinpointing CHST6 as a top prognostic gene consistently upregulated in both LUAD and IPF. Functional validation confirmed that CHST6 promotes lung cancer cell proliferation, migration, and invasion. In conclusion, our findings elucidate the shared molecular landscape of LUAD and IPF and propose that CHST6 is a promising co-disease therapeutic target.

6 October 2026 in Nature Aging
Verified
Journal Article
Open access
PDF file
XWXinyuan Wang
Xinyuan Wang
YLYaru Luo
Yaru Luo
SHSiyu He
Siyu He
YLYing Lu
Ying Lu
YGYanqiu Gong
Yanqiu Gong
LDLunzhi Dai
Lunzhi Dai